Objective: To confirm dengue infection among Russian tourists returned from Southeast and Mexico in 2010-2013 with clinical signs of infection. Methods: Blood and serum samples from patients were collected. NSI antigen and human IgMlIgG antibodies to dengue virus were identified using commercial tests manufactured by "Standard Diagnostics, INC.", Korea. EUSA test was used for the quantitative analyses of human IgMlIgG antibodies to dengue virus ('Orgenics Ltd.", Israel). Viral RNA was detected using commercial real-time PCR tests manufactured by "Genome Diagnostics Pvt. Ltd.", India and "Vector", Russia. Genotypes of revealed dengue viruses were determined employing nucleotide sequencing and phylogenetic analysis of 5'-UTR of the viral genome. Results: A total of 98 collected blood samples were analyzed. Fifty samples were positive for at least one of four markers of dengue infection. IgM to dengue virus were revealed in 38 samples, in 25 samples IgMwere combined with IgG. NSI antigen was detected in 43 samples. 22 serum samples were positive for dengue virus RNA. The majority of samples (12 patients) from tourists returned from Thailand were positive for genotype 1 of dengue virus, 2nd and 4th genotype were identified each in 1 patient. Conclusions: Due to laboratory confirmed cases of imported dengue fever in Russia, the differential diagnosis of dengue is strictly recommended for tourists returning from endemic areas.
Introduction
Dengue fever is endemic in more than 100 countries in Africa, the Americas, Eastern Mediterranean, Southeast Asia and the Western Pacific. According to the WHO data, up to 100 million people are infected every year worldwide with dengue fever [ The research seeks to prove the significance of dengue fever threat for such non-endemic territories like Russia.
The purpose of the work was to confirm dengue infection among Russian tourists returned from Southeast and Mexico in 2010-2013 with clinical signs of infection. In accordance with protocol for differential diagnosis of dengue fever approved by WHO all the samples were tested for markers of infections caused by Lassa, Machupo, Junin, Marburg, Ebola, Japanese encephalitis, Chikungunya viruses using PCR kits ("Vector", Russia). Also all the samples were tested for markers of West Nile fever, tick-born encephalitis using"AmpliSense" PCR kits (Central Research Institute of Epidemiology, Russia) and "Vector-PCR-RT-RG" ("Vector", Russia) according to the manufacturer's instructions.
Materials and methods
DNA fragments obtained from PCR amplification were analyzed by gel electrophoresis using 2 % agarose and purified for subsequent determination of the nucleotide sequence using "Gel Extraction Kit" (" Qiagen" , Netherlands). All the samples were analyzed twice in independent experiments.
Determination of the nucleotide sequence was carried out on ABI 3130xIDNA Analysis System ("Hitachi", Japan) using "BigDye Terminator v3.1 Cycle sequencing Kit" (Applied Biosystems, USA). Phylogenetic analysis carried out using the software MEGA 5 (USA) and Lasergene 9 ("DNASTAR", USA).
Results
In total 98 samples were analyzed for markers of dengue fever from May 2010 to May 2013 year. The samples were mostly collected from November to April (some samples were collected in May and June). This could be explained by active visiting of Southeast Asian countries by tourists, where the peak holiday season is from November to February.
These cases with dengue fever were from 15 regions of Russian Federation, including 3 cases in 2010, 4 cases in 2011, 13 cases in 2012 and 30 cases in 2013. Female cases accounted for 45%, with average age as 35 yrs; while male cases accounted for 55%, with average age as 42 yrs. At least 1 of 4 markers of dengue fever infection (viral RNA, NSI antigen, IgMlIgG antibodies to dengue virus) was found in 50 samples. The positive rate of NSI antigen in the blood was 78%. In most samples titer of IgM antibodies (70%, M cp=188± 71) was higher than IgG (44%, M cp=45±67) (the IgMlIgG ratio ranged from 2 to 64). In two patients in febrile phase the IgMi IgG ratio was found lower than 1.78 (4%). And the positive rate of PCR was 28%.
None of studied samples was positive for Lassa, Machupo, Junin, Marburg, Ebola, Japanese and tick-born encephalitis, Chikungunya, West Nile viruses.
More than 40 of the observed patients were treated in hospital communicable diseases unit, while the physical condition of 28 patients was evaluated as moderate complexity, and 14 patients had severe physical condition.
All cases had favorable prognosis. From outpatient cards is
known that all the infections were accompanied by typical signs of dengue fever: fever, arthralgia, myalgia, weakness, throat hyperemia, hepatomegaly, headache, splenomegaly, eye pain, watery diarrhea. Fever in all cases reached the maximum severity by the first day from the onset of the illness. Febrile temperature decreased by 4-8 day from the onset of illness to subfebrill or normal. Hemorrhagic rash was found on the skin surfaces of 16 patients (32%), shortterm hemorrhagic manifestations were found in 4 patients 
Discussion
According to regional office of the WHO for South-East Asia, 9418 (7 lethal) cases of dengue fever were registered in Thailand from 1 January to 10 May 2011, while 16110 (20 lethal) cases were registered during the same period of the previous year. In total 80065 and 57948 cases of dengue fever were registered in Indonesia and Thailand in 2010, respectivelyltzl,
The peak incidence of dengue fever in Indonesia is occurring in January-February, while in Thailand the majority of dengue fever cases are registered in July-September. were collected on the 2nd week and later from the onset of the infection).
IgMtiter during the re-infection caused by another subtype of dengue virus is significantly lower than during the first meeting with antigenltl. This observation is an important prognostic sign, while re-infection with the dengue virus is a risk factor for severe complications and deathlie-isl,
The analysis showed that only 2 patients during the fibril period had the IgMlIgG ratio lower than 1.78, it can indicate re-infection with dengue virus. The course of the disease in these two patients was assessed as severe. The epidemiological investigation revealed that these patients have visited countries of Southeast Asia.
In conclusion, due to laboratory confirmed cases of imported dengue fever in Russia, the differential diagnosis of dengue is strictly recommended in tourists returning from endemic areas.'
